The current NLTX market cap is 156.75M. The company's latest EPS is USD -1.2815 and P/E is -2.72.
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 0 | 0 | 0 | 0 | 0 |
Operating Income | -13.61M | -14.25M | -15.14M | -3.07M | -5.57M |
Net Income | -13.07M | -13.45M | -14.2M | -2.09M | -4.53M |
Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 25M | 0 | 7.83M | 0 | 0 |
Operating Income | -32.62M | -70.96M | -33.73M | -60.7M | -59.1M |
Net Income | -31.59M | -69.44M | -33.28M | -60.69M | -57.56M |
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 126.58M | 115.95M | 98.46M | 94.01M | 89.59M |
Total Liabilities | 20.93M | 21.62M | 17.1M | 14.43M | 14.35M |
Total Equity | 105.65M | 94.33M | 81.36M | 79.58M | 75.24M |
Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 77.62M | 147.02M | 210.52M | 163.26M | 115.95M |
Total Liabilities | 4.95M | 5.34M | 19.3M | 20.4M | 21.62M |
Total Equity | 72.67M | 141.69M | 191.22M | 142.86M | 94.33M |
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | -34.67M | -45.61M | -13.03M | -17.08M | -21.35M |
Investing | -67.6M | -59.13M | 10.71M | 10.3M | 8.68M |
Financing | 143k | 161k | -66k | -360k | -361k |
Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | -31.58M | -15.39M | -24.58M | -47.56M | -45.61M |
Investing | 55.95M | -688k | -2.22M | -3.26M | -59.13M |
Financing | 570k | 82.24M | 77.14M | 732k | 161k |
Market Cap | 156.75M |
Price to Earnings Ratio | -2.72 |
Price to Sales Ratio | 0 |
Price to Cash Ratio | 4.14 |
Price to Book Ratio | 1.66 |
Dividend Yield | - |
Shares Outstanding | 44.91M |
Average Volume (1 week) | 0 |
Average Volume (1 Month) | 0 |
52 Week Change | 7.38% |
52 Week High | 4.70 |
52 Week Low | 3.05 |
Spread (Intraday) | 0.14 (3.93%) |
Company Name | Neoleukin Therapeutics Inc |
Address |
corporation trust center 1209 orange st wilmington, delaware 19802 |
Website | https://www.neoleukin.com |
Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.